Stock analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
View Our Latest Report on SNES
SenesTech Stock Down 8.8 %
SenesTech (NASDAQ:SNES – Get Free Report) last issued its quarterly earnings results on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.71 million. Research analysts predict that SenesTech will post -10.22 EPS for the current fiscal year.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- How to Most Effectively Use the MarketBeat Earnings Screener
- How to Build the Ultimate Everything ETF Portfolio
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Comparing and Trading High PE Ratio Stocks
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.